Syncom Formulations (India) Limited reported earnings results for the fourth quarter ended March 31, 2023. For the fourth quarter, the company reported sales was INR 609.8 million compared to INR 582.31 million a year ago. Revenue was INR 677.49 million compared to INR 639.33 million a year ago.

Net income was INR 84.74 million compared to INR 47.58 million a year ago. Basic earnings per share from continuing operations was INR 0.1 compared to INR 0.05 a year ago. Diluted earnings per share from continuing operations was INR 0.1 compared to INR 0.05 a year ago.